Targeted probiotic shows promiseTargeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis.
High relevance to colitis treatment
We explored the effectiveness of a specially engineered probiotic yeast, Saccharomyces boulardii, aimed at treating colitis. By cleverly binding this probiotic to proteins in the gut, we managed to significantly extend its stay in the gastrointestinal tract. This allowed us to observe a noteworthy increase in probiotic levels in the colon.
Importantly, our findings showed improvements in critical health markers, such as colon length and inflammation scores. This innovative approach suggests that targeted probiotics could be a game changer in managing inflammatory bowel diseases.
Read More
Probiotic shows anti-inflammatory efficacyEfficient surface display of single-chain variable fragments against tumor necrosis factor α on engineered probiotic Saccharomyces boulardii and its application in alleviating intestinal inflammation in vivo.
High relevance for gut health
We explored the potential of Saccharomyces boulardii, a probiotic, to ease gut inflammation. This study developed a unique system that displayed specific anti-inflammatory proteins on the probiotic. By optimizing these proteins' expression, the engineered S. boulardii samples were tested on a colitis mouse model.
The results indicated a notably lower disease activity and a reduction in inflammation markers, suggesting that this innovative approach could be effective in improving intestinal health. Overall, our findings highlight the probiotic's promise in managing inflammatory conditions.
Read More
Saccharomyces boulardii as a postbioticA Saccharomyces boulardii-derived antioxidant protein, thioredoxin, ameliorates intestinal inflammation through transactivating epidermal growth factor receptor.
Study demonstrates therapeutic potential
We explored the impact of Saccharomyces boulardii on colitis, aiming to understand its potential benefits for gut health. Our findings revealed that an oral dose of S. boulardii supernatant helped ease intestinal inflammation and reinforced the gut barrier.
A key player in this process is thioredoxin (Trx), a protein that activated important pathways to reduce inflammation and oxidative stress. By promoting the activation of the epidermal growth factor receptor, Trx showed promise as a new postbiotic treatment for colitis.
However, while these results are encouraging, more research is needed to fully comprehend its long-term effects.
Read More
Heat-killed Saccharomyces boulardii benefits UCHeat-Killed Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis by Restoring the Intestinal Barrier, Reducing Inflammation, and Modulating the Gut Microbiota.
Relevant potential treatment evaluation
This study delved into the effects of heat-killed Saccharomyces boulardii on ulcerative colitis, aiming to uncover its potential as a treatment option. We observed that this treatment significantly restored body weight, reduced inflammation, and improved gut barrier function in mice with colitis. It also effectively modulated gut microbiota, outperforming other treatments like β-glucan.
Overall, heat-killed Saccharomyces boulardii presents a promising new approach for those suffering from ulcerative colitis, enhancing their quality of life.
Read More
We investigated whether Saccharomyces boulardii could protect mice from experimental colitis. Over three weeks, treated mice showed less weight loss, reduced colon damage, and improved gut barrier function compared to untreated ones.
By promoting beneficial bacteria and reducing harmful ones, it enhanced microbial diversity and transformed the gut's metabolite profile. These beneficial changes correlated with lower inflammation, suggesting that S. boulardii might be a promising treatment option for colitis based on its effects on gut health.
Read More